Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing

Human mesenchymal stromal cell (hMSC) therapy has been gaining immense interest in regenerative medicine and quite recently for its immunomodulatory properties in COVID-19 treatment. Currently, the use of hMSCs for various diseases is being investigated in >900 clinical trials. Despite the huge e...

Descripció completa

Dades bibliogràfiques

Autors principals:	Premkumar Jayaraman, Ryan Lim, Jacqueline Ng, Mohan C. Vemuri
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-04-01
Col·lecció:	Frontiers in Cell and Developmental Biology
Matèries:	mesenchymal stromal cells cell therapy GMP manufacturing closed and automation systems characterization and potency regulatory compliance
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fcell.2021.648472/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!